These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 17295882

  • 1. Long-term results with azathioprine therapy in patients with corticosteroid-dependent Crohn's disease: open-label prospective study.
    Chebli JM, Gaburri PD, De Souza AF, Pinto AL, Chebli LA, Felga GE, Forn CG, Pimentel CF.
    J Gastroenterol Hepatol; 2007 Feb; 22(2):268-74. PubMed ID: 17295882
    [Abstract] [Full Text] [Related]

  • 2. Azathioprine therapy in steroid-dependent patients with Crohn disease: results of a 10-year longitudinal follow-up study.
    Pinto AL, Chebli LA, Ribeiro MS, Pace FH, Moraes JP, do Amaral FJ, Gaburri PD, Meirelles de Souza AF, Chebli JM.
    Med Sci Monit; 2009 May; 15(5):PI19-26. PubMed ID: 19396048
    [Abstract] [Full Text] [Related]

  • 3. Early onset steroid-dependent ulcerative colitis is a predictor of azathioprine response: a longitudinal 12-month follow-up study.
    Chebli LA, Felga GG, Chaves LD, Pimentel FF, Guerra DM, Gaburri PD, Zanini A, Chebli JM.
    Med Sci Monit; 2010 Feb; 16(2):PI1-6. PubMed ID: 20110928
    [Abstract] [Full Text] [Related]

  • 4. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X, Serre-Debeauvais F, Phelip JM, Faucheron JL, Hardy G, Chartier A, Helluwaert F, Bessard G, Bonaz B.
    Aliment Pharmacol Ther; 2005 Apr 01; 21(7):829-39. PubMed ID: 15801918
    [Abstract] [Full Text] [Related]

  • 5. Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's disease.
    Schmidt C, Wittig BM, Moser C, Zeitz M, Stallmach A.
    Aliment Pharmacol Ther; 2006 Jul 15; 24(2):343-50. PubMed ID: 16842461
    [Abstract] [Full Text] [Related]

  • 6. A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease.
    Reinisch W, Panés J, Lémann M, Schreiber S, Feagan B, Schmidt S, Sturniolo GC, Mikhailova T, Alexeeva O, Sanna L, Haas T, Korom S, Mayer H.
    Am J Gastroenterol; 2008 Sep 15; 103(9):2284-92. PubMed ID: 18671816
    [Abstract] [Full Text] [Related]

  • 7. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?
    Charpignon C, Beau P.
    Gastroenterol Clin Biol; 2008 Feb 15; 32(2):153-7. PubMed ID: 18343615
    [Abstract] [Full Text] [Related]

  • 8. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC, Pintoffl JP, Sturm A, Wiedenmann B, Dignass AU.
    Am J Gastroenterol; 2006 May 15; 101(5):1048-56. PubMed ID: 16573777
    [Abstract] [Full Text] [Related]

  • 9. Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis.
    Hibi T, Naganuma M, Kitahora T, Kinjyo F, Shimoyama T.
    J Gastroenterol; 2003 May 15; 38(8):740-6. PubMed ID: 14505127
    [Abstract] [Full Text] [Related]

  • 10. Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial.
    Lémann M, Mary JY, Duclos B, Veyrac M, Dupas JL, Delchier JC, Laharie D, Moreau J, Cadiot G, Picon L, Bourreille A, Sobahni I, Colombel JF, Groupe d'Etude Therapeutique des Affections Inflammatoires du Tube Digestif (GETAID).
    Gastroenterology; 2006 Apr 15; 130(4):1054-61. PubMed ID: 16618399
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of azathioprine maintenance therapy in a group of Crohn's disease patients in China.
    Zheng JJ, Chu XQ, Shi XH, Zhou CL, Seng BW.
    J Dig Dis; 2008 May 15; 9(2):84-8. PubMed ID: 18419641
    [Abstract] [Full Text] [Related]

  • 12. Azathioprine withdrawal in patients with Crohn's disease maintained on prolonged remission: a high risk of relapse.
    Treton X, Bouhnik Y, Mary JY, Colombel JF, Duclos B, Soule JC, Lerebours E, Cosnes J, Lemann M, Groupe D'Etude Thérapeutique Des Affections Inflammatoires Du Tube Digestif (GETAID).
    Clin Gastroenterol Hepatol; 2009 Jan 15; 7(1):80-5. PubMed ID: 18849016
    [Abstract] [Full Text] [Related]

  • 13. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K, Ludwig D, Stahl M, David-Walek T, Stange EF.
    Am J Gastroenterol; 1998 Oct 15; 93(10):1860-6. PubMed ID: 9772045
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcome of Crohn's disease following corticosteroid-induced remission.
    Papi C, Festa V, Leandro G, Moretti A, Tanga M, Koch M, Capurso L.
    Am J Gastroenterol; 2007 Apr 15; 102(4):814-9. PubMed ID: 17222316
    [Abstract] [Full Text] [Related]

  • 15. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease.
    Baert F, Moortgat L, Van Assche G, Caenepeel P, Vergauwe P, De Vos M, Stokkers P, Hommes D, Rutgeerts P, Vermeire S, D'Haens G, Belgian Inflammatory Bowel Disease Research Group, North-Holland Gut Club.
    Gastroenterology; 2010 Feb 15; 138(2):463-8; quiz e10-1. PubMed ID: 19818785
    [Abstract] [Full Text] [Related]

  • 16. A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.
    Mantzaris GJ, Sfakianakis M, Archavlis E, Petraki K, Christidou A, Karagiannidis A, Triadaphyllou G.
    Am J Gastroenterol; 2004 Jun 15; 99(6):1122-8. PubMed ID: 15180735
    [Abstract] [Full Text] [Related]

  • 17. Azathioprine as a postoperative prophylaxis reduces symptoms in aggressive Crohn's disease.
    Myrelid P, Svärm S, Andersson P, Almer S, Bodemar G, Olaison G.
    Scand J Gastroenterol; 2006 Oct 15; 41(10):1190-5. PubMed ID: 16990204
    [Abstract] [Full Text] [Related]

  • 18. Effect of long-term low-dose prednisone on height velocity and disease activity in pediatric and adolescent patients with Crohn disease.
    Navarro FA, Hanauer SB, Kirschner BS.
    J Pediatr Gastroenterol Nutr; 2007 Sep 15; 45(3):312-8. PubMed ID: 17873743
    [Abstract] [Full Text] [Related]

  • 19. Clinical trial: cyclophosphamide pulse therapy - a promising therapeutic alternative in refractory Crohn's disease.
    Schmidt KJ, Fellermann K, Wellhöner P, Weitz G, Homann N, Herrlinger K, Lehnert H, Ludwig D, Büning J.
    Aliment Pharmacol Ther; 2009 Jun 15; 29(12):1230-9. PubMed ID: 19302074
    [Abstract] [Full Text] [Related]

  • 20. A pilot study comparing hydrocortisone premedication to concomitant azathioprine treatment in preventing loss of response to infliximab.
    Mantzaris GJ, Viazis N, Petraki K, Papamichael K, Theodoropoulos I, Roussos A, Karakoidas C, Koilakou S, Raptis N, Smyrnidis A, Agalos G, Karamanolis DG.
    Eur J Gastroenterol Hepatol; 2009 Sep 15; 21(9):1042-8. PubMed ID: 20139856
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.